Literature DB >> 15517595

Role of AKT/PKB signaling in fibroblast growth factor-1 (FGF-1)-induced angiogenesis in the chicken chorioallantoic membrane (CAM).

Reza Forough1, Brian Weylie, Chirag Patel, Sandy Ambrus, Ugra S Singh, James Zhu.   

Abstract

Transfection of chicken chorioallantoic membranes (CAMs) with a chimeric secreted version of fibroblast growth factor-1 (sp-FGF-1) gene construct leads to a significant increase in vascularization. Though FGF-stimulated angiogenesis has been extensively studied, the molecular mechanisms regulating FGF-1-induced angiogenesis are poorly understood in vivo. This study was designed to investigate the role of the AKT (PKB) kinase signaling pathway in mediating sp-FGF-1-induced angiogenesis in the chicken CAM. The involvement of the AKT pathway was demonstrated by up-regulation of AKT1 mRNA expression in sp-FGF-1 compared to vector alone control transfected CAMs as demonstrated by real-time RT-PCR. Western analysis using an antibody specific to the activated AKT (phosphorylated AKT), demonstrated an increase in AKT activity in sp-FGF-1 compared to vector control transfected CAMs. More importantly, the AKT inhibitor ML-9 significantly reduced sp-FGF-1-induced angiogenesis in CAMs. These results indicate that AKT signaling plays a role in FGF-1-stimulated angiogenesis in vivo and the AKT pathway may serve as a therapeutic target for angiogenesis-associated diseases. 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15517595     DOI: 10.1002/jcb.20274

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  11 in total

Review 1.  The chicken chorioallantoic membrane model in biology, medicine and bioengineering.

Authors:  Patrycja Nowak-Sliwinska; Tatiana Segura; M Luisa Iruela-Arispe
Journal:  Angiogenesis       Date:  2014-08-20       Impact factor: 9.596

Review 2.  Metabolic Messengers: fibroblast growth factor 1.

Authors:  Emanuel Gasser; Gencer Sancar; Michael Downes; Ronald M Evans
Journal:  Nat Metab       Date:  2022-06-09

Review 3.  FGFs: crucial factors that regulate tumour initiation and progression.

Authors:  Qian Jing; Yuanyuan Wang; Hao Liu; Xiaowei Deng; Lin Jiang; Rui Liu; Haixing Song; Jingyi Li
Journal:  Cell Prolif       Date:  2016-07-07       Impact factor: 6.831

Review 4.  Angiogenesis and Anti-Angiogenic Therapy in Gastric Cancer.

Authors:  Henrik Nienhüser; Thomas Schmidt
Journal:  Int J Mol Sci       Date:  2017-12-23       Impact factor: 5.923

5.  The role of fibroblast growth factor 1 and 2 on the pathological behavior of valve interstitial cells in a three-dimensional mechanically-conditioned model.

Authors:  Ngoc Thien Lam; Ishita Tandon; Kartik Balachandran
Journal:  J Biol Eng       Date:  2019-05-27       Impact factor: 4.355

Review 6.  Inhibition of FGF-FGFR and VEGF-VEGFR signalling in cancer treatment.

Authors:  Guihong Liu; Tao Chen; Zhenyu Ding; Yang Wang; Yuquan Wei; Xiawei Wei
Journal:  Cell Prolif       Date:  2021-03-02       Impact factor: 6.831

Review 7.  Fibroblast Growth Factor Receptors (FGFRs) and Noncanonical Partners in Cancer Signaling.

Authors:  Harriet R Ferguson; Michael P Smith; Chiara Francavilla
Journal:  Cells       Date:  2021-05-14       Impact factor: 6.600

Review 8.  A Network Map of FGF-1/FGFR Signaling System.

Authors:  Rajesh Raju; Shyam Mohan Palapetta; Varot K Sandhya; Apeksha Sahu; Abbas Alipoor; Lavanya Balakrishnan; Jayshree Advani; Bijesh George; K Ramachandra Kini; N P Geetha; H S Prakash; T S Keshava Prasad; Yu-Jung Chang; Linyi Chen; Akhilesh Pandey; Harsha Gowda
Journal:  J Signal Transduct       Date:  2014-04-16

Review 9.  Molecular mediators of peritoneal metastasis in pancreatic cancer.

Authors:  Leela Rani Avula; Brendan Hagerty; Christine Alewine
Journal:  Cancer Metastasis Rev       Date:  2020-08-11       Impact factor: 9.264

Review 10.  Gastric carcinogenesis: a comprehensive review of the angiogenic pathways.

Authors:  Alicja Forma; Magdalena Tyczyńska; Paweł Kędzierawski; Klaudyna Gietka; Monika Sitarz
Journal:  Clin J Gastroenterol       Date:  2020-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.